Member Info for dafad

Gerard J Brandon
@gjbrandon
Replying to
@BlogShrey
The data accumulated from real-world product testing adds to the extensive library of 13 years of #Labskin data. Applied #AI from these studies generate revenue and moves us to the next stage of testing products on a virtual virus model

Emperical used in the Rns several times

https://en.wikipedia.org/wiki/Empirical_evidence

Deepverge PLC

27 November 2020

27 November 2020

DeepVerge PLC

(AIM:DVRG)

("DeepVerge" or "the Company")

Interim analysis from University of Aberdeen Labskin study demonstrates ability to host

SARS-CoV-2 virus on Labskin cloned human skin microbiome

Breakthrough results allow real-world testing of anti-viral compounds without human volunteers

Study extended to investigate additional COVID-19 behaviours on skin

DeepVerge announces interim results from its Labskin partnership with University of Aberdeen following analysis of a study to investigate the behaviour of SARS-CoV-2 virus on Labskin's cloned human skin microbiome to enable testing of COVID-19 anti-viral and dental products.

Labskin scientists have successfully populated and maintained the SARS-CoV-2 virus on skin models creating a breakthrough environment that enables testing of household chemicals, anti-viral products, skin and health care products, and their effect on the human skin microbiome as well as their efficacy at killing the virus over long periods of time.

The DeepVerge study is designed to investigate:

-- The transmissibility from surfaces to airways via skin by measuring its viability when recovered from surface(s) to skin and skin to skin;

-- What sanitisers kill the virus on skin (this is anecdotally assumed to be correct based on the World Health Organisation ("WHO") research on other bacteria, but not proven for Covid);

-- The reduction of titre and/or virulence;
-- The ability of the virus to activate innate immune response on the human living tissue (Labskin model); and

-- How long the virus lives on skin.
These results validate Labskin's ability to provide access to real-world clones of the human skin microbiome while removing the risk of transmission of the virus to human volunteers. For the first time, in safety, clients can test their products, ingredients, treatments and therapies on SARS-CoV-2 and potentially other dangerous viruses and pathogens in real-world environments.

DeepVerge has extended the investigation and will include:

-- Viability of the virus when transferred as full coronavirus particles from plastic and metal surfaces to the laboratory grown human skin model and the potential risk for infection through the skin;

-- Ability of SARS-CoV-2 to activate innate immune response on the Labskin model; and
-- Ability to reproduce on the skin and how long it remains viable - and therefore infectious.
Gerard Brandon, CEO of DeepVerge plc, commented:

"Society has depended on anecdotal or theoretical evidence to determine how infectious skin is, as humans touch surfaces and each other. The work in Aberdeen provides factual data and empirical evidence of surface to skin and skin to skin transferability to provide quantifiable infection risks. The body of research, protocols and methods created on Labskin, working with the real virus, offers confirmation and sets standards

I have a sneaky suspicion that the GPB 4m will be blown out the water

November 2020

25 November 2020

DeepVerge PLC

("DeepVerge" or "the Company")

Investor presentation and corporate update following Modern Water plc acquisition

DeepVerge (LSE:DVRG.L), the scientific research and AI-as-a-Service company, is pleased to announce that Gerry Brandon, Chief Executive Officer, will be presenting at an investor webinar being hosted jointly by Turner Pope Investments (TPI) Ltd and Vox Markets.

The event will be held on Tuesday 1(st) December 2020 at 2pm. Please register your interest at https://**********.brand.live/c/deepverge-webinar

Gerard Brandon, CEO of DeepVerge, Commented:

"Deepverge is expanding, with organic revenue growth alone, despite COVID, guided at GBP4m for 2020, including an increase in revenues by 300% in H2 2020, up from GBP1m in H1 2020. Following the recent acquisition of Modern Water plc, we will now have sales offices and laboratories for Labskin and Rinocloud AI services in the US, Ireland, UK, China and Japan. This global expansion provides access to a growing list of household name clients, that includes Unilever, L'Oréal, Estee Lauder, Walgreens Boots Alliance, Amway and L'Occitane, cross-selling products and services from each division and serving the environment, cosmetics and pharma sectors worldwide.

"The presentation will provide an update on sales, marketing, supply chain management of products and services under development in a post-COVID world with insight into what is expected to come in 2021 and 2022."

For further information please contact:

https://www.nytimes.com/2020/11/24/well/live/covid-best-masks.html?surface=most-popular&fellback=false&req_id=370440093&algo=bandit-all-surfaces&imp_id=349756947&action=click&module=Most%20Popular&pgtype=Homepage

Randomized, placebo-controlled trial of convalescent plasma(CP) for severe #COVID19: "no significant differences...in clinical status or overall mortality"
@NEJM

"We believe the use of CP as a standard of care....should be reevaluated." https://nejm.org/doi/full/10.1056/NEJMoa2031304?query=featured_home

https://www.dailymail.co.uk/health/article-8982023/Coronavirus-STOPPED-70-public-wore-face-masks-study-suggests.html

Imho

https://www.bbc.co.uk/news/uk-wales-55043109

6.9%

I know the team,it is led by a pulmonary physician a colleague of owers,who actualy with whom we have collaborated

is no ordinary guy
Jean-Laurent Casanova, MD, PhD
Investigator / 2014—Present
Dr. Casanova is a professor, senior attending physician, and head of the St. Giles Laboratory of Human Genetics of Infectious Diseases at The Rockefeller University, as well as a visiting professor at the Necker Hospital for Sick Children, University of Paris.

https://www.hhmi.org/scientists/jean-laurent-casanova

This guy seems to know the guys at Sng,listen from 1hr 33 minhttps://www.youtube.com/watch?v=zfKcUOmJqC4

I'm sure RM mentioned a new/additional supplier for the protein,anyone able to confirm

Apoligies if I have the username wrong but was it Citytrader that said the India news was in the pipeline,
I for one do not doubt your integrity for a second but would be interested on your views about RM not been aware of any
India contracts

Tomorrow's Global COVID Lab Meeting will be with Eleanor Fish, Professor of Immunology at
@UofT
. Dr. Fish studies #interferons – antiviral proteins which help prevent or treat #COVID_19. Sign up for Nov 19, 10:00 AM EST: https://bit.ly/2ZYNyX5.

https://www.the-scientist.com/news-opinion/seeking-an-early-covid-19-drug-researchers-look-to-interferons-67753

HI guys how do i listen in to the webinar any one able to point me i the right direction

We are gathering interest

https://www.nbcnews.com/health/health-news/breakthrough-finding-reveals-why-certain-covid-19-patients-die-n1247576

why